title: Dopamine Genetics and Function in Food and Substance Abuse.
abstract: Having entered the genomics era with confidence in the future of medicine, including psychiatry, identifying the role of DNA and polymorphic associations with brain reward circuitry has led to a new understanding of all addictive behaviors. It is noteworthy that this strategy may provide treatment for the millions who are the victims of "Reward Deficiency Syndrome" (RDS) a genetic disorder of brain reward circuitry. This article will focus on drugs and food being mutuality addictive, and the role of dopamine genetics and function in addictions, including the interaction of the dopamine transporter, and sodium food. We will briefly review our concept that concerns the genetic antecedents of multiple-addictions (RDS). Studies have also shown that evaluating a panel of established reward genes and polymorphisms enables the stratification of genetic risk to RDS. The panel is called the "Genetic Addiction Risk Score (GARS)", and is a tool for the diagnosis of a genetic predisposition for RDS. The use of this test, as pointed out by others, would benefit the medical community by identifying at risk individuals at a very early age. We encourage, in depth work in both animal and human models of addiction. We encourage further exploration of the neurogenetic correlates of the commonalities between food and drug addiction and endorse forward thinking hypotheses like "The Salted Food Addiction Hypothesis".
authors.affiliation: Department of Psychiatry & McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida, USA ; Centre for Genomics and Applied Gene Technology, Institute of Integrative Omics and Applied Biotechnology (IIOAB), Nonakuri, Purba Medinipur, West Bengal, India ; Department of Nutrigenomics, LifeGen, Inc., Austin, Texas, USA.
authors.forename: K
authors.initials: K
authors.lastname: Blum
authors.forename: M
authors.initials: M
authors.lastname: Oscar-Berman
authors.forename: D
authors.initials: D
authors.lastname: Barh
authors.forename: J
authors.initials: J
authors.lastname: Giordano
authors.forename: Ms
authors.initials: M
authors.lastname: Gold
keywords: Dopaminergic gene polymorphisms; Food addiction; Neurogenetics; Reward Deficiency Syndrome (RDS); Substance Use Disorder (SUD)
references.citation: Semin Cell Dev Biol. 2009 Jun;20(4):441-54
references.pmid: 19560049
references.citation: J Neurosci. 2002 Jan 15;22(2):389-95
references.pmid: 11784783
references.citation: Psychiatry Res. 2009 Dec 30;170(2-3):199-203
references.pmid: 19906444
references.citation: Am J Psychiatry. 2007 Aug;164(8):1149-59
references.pmid: 17671276
references.citation: Psychiatr Pol. 2008 May-Jun;42(3):453-61
references.pmid: 19899572
references.citation: Alcohol Clin Exp Res. 2011 Sep;35(9):1625-34
references.pmid: 21554332
references.citation: Addict Biol. 2012 Jan;17(1):95-107
references.pmid: 21309956
references.citation: Psychiatry Res. 2011 Feb 28;185(3):382-6
references.pmid: 20850185
references.citation: Psychopharmacology (Berl). 2011 May;215(1):13-22
references.pmid: 21140256
references.citation: Drug Alcohol Depend. 1995 May;38(2):95-137
references.pmid: 7671769
references.citation: Adv Pharmacol. 1998;42:486-90
references.pmid: 9327945
references.citation: J Neurosci. 1997 Feb 1;17(3):960-74
references.pmid: 8994051
references.citation: Methods Enzymol. 1998;296:498-514
references.pmid: 9779470
references.citation: Am J Physiol. 1999 May;276(5):R1339-45
references.pmid: 10233025
references.citation: Am J Med Genet. 2000 Jun 12;96(3):302-6
references.pmid: 10898904
references.citation: J Neurophysiol. 1998 Jul;80(1):1-27
references.pmid: 9658025
references.citation: Am J Hum Genet. 1995 Apr;56(4):993-8
references.pmid: 7717410
references.citation: Hum Mol Genet. 1993 Mar;2(3):335
references.pmid: 8098980
references.citation: J R Soc Med. 1996 Jul;89(7):396-400
references.pmid: 8774539
references.citation: Hum Mutat. 2004 Jun;23(6):540-5
references.pmid: 15146457
references.citation: J Neurosci. 2007 Sep 19;27(38):10196-209
references.pmid: 17881525
references.citation: Pharmacogenet Genomics. 2009 Jul;19(7):513-27
references.pmid: 19603545
references.citation: Obes Rev. 2013 Jan;14(1):2-18
references.pmid: 23016694
references.citation: Mol Psychiatry. 1997 May;2(3):251-4
references.pmid: 9152990
references.citation: Psychiatry Res. 1998 Nov 16;81(2):133-47
references.pmid: 9858031
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 5;144B(4):541-50
references.pmid: 17440978
references.citation: Eur J Neurosci. 2006 Jan;23(1):180-6
references.pmid: 16420427
references.citation: Brain Res. 2012 Jan 18;1433:80-4
references.pmid: 22154407
references.citation: Neuroendocrinology. 1998 Jul;68(1):11-20
references.pmid: 9695934
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2003 Jan 1;116B(1):103-25
references.pmid: 12497624
references.citation: Eur J Neurosci. 2009 Apr;29(8):1678-91
references.pmid: 19385990
references.citation: Brain Res Mol Brain Res. 1994 May;23(3):246-52
references.pmid: 8057781
references.citation: Neuropharmacology. 2011 Dec;61(7):1109-22
references.pmid: 21459101
references.citation: Alcohol. 2008 Mar;42(2):77-81
references.pmid: 18358985
references.citation: Behav Neurosci. 1997 Jun;111(3):606-11
references.pmid: 9189275
references.citation: Arch Gen Psychiatry. 2011 Mar;68(3):283-94
references.pmid: 21383264
references.citation: Eur Psychiatry. 2005 May;20(3):304-6
references.pmid: 15935433
references.citation: Brain Res Mol Brain Res. 2004 May 19;124(2):134-42
references.pmid: 15135221
references.citation: Psychiatry Res. 2001 Nov 1;104(2):109-17
references.pmid: 11711165
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):310-7
references.pmid: 17192955
references.citation: Alcohol. 2012 Sep;46(6):577-84
references.pmid: 22749340
references.citation: Neuropsychopharmacology. 2005 Feb;30(2):417-22
references.pmid: 15525999
references.citation: Neurochem Res. 1993 Aug;18(8):927-36
references.pmid: 8371835
references.citation: Psychiatry Res. 2004 Jul 15;127(3):171-83
references.pmid: 15296817
references.citation: Mol Psychiatry. 1998 Jul;3(4):333-6
references.pmid: 9702742
references.citation: J Addict Med. 2009 Mar;3(1):8-18
references.pmid: 21603099
references.citation: Nat Rev Neurosci. 2003 Jan;4(1):13-25
references.pmid: 12511858
references.citation: Brain Res. 2010 Nov 4;1359:227-32
references.pmid: 20801104
references.citation: Am J Psychiatry. 2001 Jul;158(7):1052-7
references.pmid: 11431226
references.citation: Curr Pharm Des. 2012;18(1):113-8
references.pmid: 22236117
references.citation: Biol Res Nurs. 2012 Apr;14(2):188-96
references.pmid: 21613340
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):382-7
references.pmid: 22877924
references.citation: Mol Psychiatry. 1999 Sep;4(5):484-7
references.pmid: 10523822
references.citation: FASEB J. 2006 Nov;20(13):2223-33
references.pmid: 17077299
references.citation: Arch Gen Psychiatry. 1991 Jul;48(7):648-54
references.pmid: 2069496
references.citation: Neuropsychopharmacology. 2006 Jun;31(6):1335-44
references.pmid: 16395310
references.citation: Med Hypotheses. 2009 May;72(5):518-26
references.pmid: 19223127
references.citation: Med Hypotheses. 2011 Apr;76(4):576-84
references.pmid: 21306831
references.citation: JAMA. 1990 Apr 18;263(15):2055-60
references.pmid: 1969501
references.citation: Arch Womens Ment Health. 2008 Dec;11(5-6):347-55
references.pmid: 18827956
references.citation: Proc Natl Acad Sci U S A. 2011 May 31;108(22):9268-73
references.pmid: 21576462
references.citation: Neurosci Biobehav Rev. 2008;32(1):20-39
references.pmid: 17617461
references.citation: Science. 1991 Oct 25;254(5031):578-9
references.pmid: 1948035
references.citation: Med Hypotheses. 2009 Dec;73(6):892-9
references.pmid: 19643550
references.citation: Adv Psychosom Med. 2011;30:22-60
references.pmid: 21508625
references.citation: Arch Gen Psychiatry. 2012 Apr;69(4):339-48
references.pmid: 22474103
references.citation: Am J Forensic Med Pathol. 2008 Dec;29(4):320-2
references.pmid: 19259017
references.citation: Nature. 1988 Dec 22-29;336(6201):783-7
references.pmid: 2974511
references.citation: Med Hypotheses. 2009 Dec;73(6):976-7
references.pmid: 19822399
references.citation: Neuroscience. 2011 Jan 13;172:139-52
references.pmid: 20969930
references.citation: Mol Biol (Mosk). 2002 Jul-Aug;36(4):593-8
references.pmid: 12173460
references.citation: Neuroreport. 2001 May 8;12(6):1103-6
references.pmid: 11338173
references.citation: Psychopharmacology (Berl). 2001 Feb;154(1):43-9
references.pmid: 11292005
references.citation: Int J Neuropsychopharmacol. 2011 Apr;14(3):377-88
references.pmid: 20860878
references.citation: Neurosci Lett. 2002 Dec 16;334(3):206-10
references.pmid: 12453630
references.citation: J Biol Chem. 1996 Aug 30;271(35):21672-80
references.pmid: 8702957
references.citation: Biol Psychiatry. 2012 Feb 15;71(4):350-7
references.pmid: 22030358
references.citation: Alcohol Alcohol. 2011 Sep-Oct;46(5):509-13
references.pmid: 21613303
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):29-37
references.pmid: 15457501
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2008 Jun 5;147B(4):517-26
references.pmid: 17948902
references.citation: Neuropsychopharmacology. 2007 Apr;32(4):955-63
references.pmid: 16943772
references.citation: Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):870-5
references.pmid: 23277566
references.citation: Funct Neurol. 1995 Jan-Feb;10(1):37-44
references.pmid: 7649500
references.citation: Physiol Behav. 2011 Jul 25;104(1):157-61
references.pmid: 21530563
references.citation: Mol Pain. 2009 Jul 01;5:37
references.pmid: 19570226
references.citation: Hum Brain Mapp. 2011 Oct;32(10):1557-65
references.pmid: 20845394
references.citation: Addict Biol. 2011 Apr;16(2):347-55
references.pmid: 20731636
references.citation: Behav Pharmacol. 2006 Sep;17(5-6):509-15
references.pmid: 16940772
references.citation: Mol Neurobiol. 2011 Oct;44(2):160-5
references.pmid: 21499988
references.citation: Neurosci Biobehav Rev. 2011 Aug;35(8):1665-86
references.pmid: 21527290
references.citation: Eur Neuropsychopharmacol. 2001 Dec;11(6):449-55
references.pmid: 11704422
references.citation: Med Hypotheses. 2005;65(4):703-7
references.pmid: 15964153
references.citation: Psychiatr Genet. 2010 Aug;20(4):140-52
references.pmid: 20505557
references.citation: Drug Alcohol Depend. 2010 Nov 1;112(1-2):134-9
references.pmid: 20598814
references.citation: Neuro Endocrinol Lett. 2008 Jun;29(3):320-7
references.pmid: 18580852
references.citation: Compr Psychiatry. 2010 Sep-Oct;51(5):510-5
references.pmid: 20728009
references.citation: Synapse. 2013 Apr;67(4):179-88
references.pmid: 23184870
references.citation: Neuroscience. 2010 Aug 11;169(1):182-94
references.pmid: 20435100
references.citation: Theor Biol Med Model. 2008 Nov 12;5:24
references.pmid: 19014506
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2006 Apr 5;141B(3):305-8
references.pmid: 16526025
references.citation: PLoS One. 2012;7(9):e44316
references.pmid: 22970199
references.citation: Pain. 2009 Dec 15;147(1-3):187-93
references.pmid: 19796878
references.citation: J Nucl Med. 2012 Jul;53(7):1065-73
references.pmid: 22689927
references.citation: J Psychoactive Drugs. 2012 Jan-Mar;44(1):38-55
references.pmid: 22641964
references.citation: Neuron. 2012 Nov 8;76(3):470-85
references.pmid: 23141060